Skip Navigation

Search

19 results found

Search Options

19 results found

Order By

Filter By

Information Type
Geographic Coverage
Publication Release
Find
Publication Coverage
From:
To:
Find
Use of NICE appraised medicines in the NHS in England - 2009, Experimental statistics

The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal process assesses the clinical and cost effectiveness of new and existing drugs and treatments, and provides guidance on their use by the NHS. As part of the Pharmaceutical Price Regulation Scheme (PPRS) agreement which came into operation on 1st January 2009, the Department of Health (DH) and the Association of the British Pharmaceutical Industry agreed that the DH would review the variation in uptake of selected medicines in the NHS in England. The NHS Information Centre was asked to produce a bulletin looking at variation in the use of these medicines in relation to the number of eligible patients as estimated by NICE. Data on the number of patients being treated is not available and so predicted use (using the average dose and average length of treatment) was compared with observed use. Data on observed use in 2009 was taken from the primary care prescribing data from NHS Prescribing Services...

Use of NICE appraised medicines in the NHS in England, Experimental statistics

The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal process assesses the clinical and cost effectiveness of new and existing drugs and treatments, and provides guidance on their use by the NHS. As part of the Pharmaceutical Price Regulation Scheme (PPRS) agreement which came into operation on 1 January 2009, the Department of Health (DH) and the Association of the British Pharmaceutical Industry agreed that the DH would review the variation in uptake of selected medicines in the NHS in England. The NHS Information Centre was asked to produce a bulletin looking at variation in the use of these medicines in relation to the number of eligible patients as estimated by NICE. Data on the number of patients being treated is not available and so predicted use (using the average dose and average length of treatment) was compared with observed use. Data on observed use in 2008 was taken from the primary care prescribing data from NHS Prescription Services...

Use of NICE appraised medicines in the NHS in England - 2010 and 2011, Experimental statistics

The National Institute for Health and Clinical Excellence (NICE) technology appraisal process assesses the clinical and cost effectiveness of new and existing drugs and treatments, and provides guidance on their use by the NHS. As part of the Pharmaceutical Price Regulation Scheme (PPRS) agreement which came into operation on 1 January 2009, the Department of Health (DH) and the Association of the British Pharmaceutical Industry agreed that the DH would review the variation in uptake of selected medicines in the NHS in England. The NHS Information Centre was asked to produce a bulletin looking at variation in the use of these medicines in relation to the number of eligible patients as estimated by NICE. Data on the number of patients being treated is not available and so predicted use (using the average dose and average length of treatment) was compared with observed use. Data on observed use in 2010 and 2011 was taken from the primary care prescribing data from NHS Prescribing...

Use of NICE-appraised Medicines in the NHS in England - 2012, Experimental statistics

Please note: on 7 February 2014 updated versions of the pdf report and the Excel spreadsheet were uploaded to correct under-reporting of the use of medicines in certain medicine groups. National figures have been revised as follows: £- Alzheimer's Disease by five per cent, £- ADHD by six per cent, £- Alitretinoin by four per cent, £- Riluzole by one per cent,£- Exenatide and Liraglutide by less than one per cent. Within these medicine groups, some sub national data is affected more than others. All other elements of the report are unaffected. This was as a result of complications arising from the extraction of data relating to prescriptions issued in hospital and dispensed in the community. The National Institute for Health and Care Excellence (NICE) technology appraisal process assesses the clinical and cost effectiveness of new and existing drugs and treatments, and provides guidance on their use by the NHS. As part of the Pharmaceutical Price Regulation

Prescribing

Find links to all our prescribing publications and data, plus supporting information and useful websites.

NICE Technology Appraisals in the NHS in England, Innovation Scorecard - to December 2015

The Innovation Scorecard reports on the use of medicines and medical technologies in the NHS in England, which have been positively appraised by the National Institute for Health and Care Excellence (NICE) since 2011. £ HSCIC has produced and published the Innovation Scorecard quarterly as an Official Statistic since January 2013 on behalf of the Office of Life Sciences. It can be used by local NHS organisations to monitor progress in implementing NICE Technology Appraisal recommendations. £ We produce the scorecard using a range of data sources from two years prior to publication and no central data collection is involved. £ Latest Data to December 2015.

NICE Technology Appraisals in the NHS in England, Innovation Scorecard - to September 2015

The Innovation Scorecard shows the use of medicines and medical technologies by primary and secondary care providers in England that have received positive NICE technology appraisals for use in the NHS since 2011. £ HSCIC produces the Innovations Scorecard quarterly for the Office of Life Sciences. It can be used by local NHS organisations to monitor progress in implementing National Institute for Health and Care Excellence (NICE) Technology Appraisal recommendations. £ We produce the scorecard using a range of data sources from two years prior to publication and no central data collection is involved. The scorecard is published every three months and was first produced in January 2013.

NICE Technology Appraisals in the NHS in England (Innovation Scorecard): to March 2016

The Innovation Scorecard reports on the use of medicines and medical technologies in the NHS in England, which have been positively appraised by the National Institute for Health and Care Excellence (NICE) since 2012. NHS Digital has produced and published the Innovation Scorecard quarterly as an Official Statistic since January 2013 on behalf of the Office of Life Sciences. It can be used by local NHS organisations to monitor progress in implementing NICE Technology Appraisal recommendations. We produce the scorecard using a range of data sources from two years prior to publication and no central data collection is involved. Please note medical technologies and industry sales data are suspended pending a review of their inclusion criteria. Latest Data to March 2016

NICE Technology Appraisals in the NHS in England - 2012, Experimental statistics, Innovation scorecard

Please note: on£21 August 2013 an updated version of the interactive spreadsheet was uploaded to correct an error in the data presented for Trastuzumab and Toclizumab, in part 3 of the interactive report. The original data swapped the data for these two drugs, so that data for Trastuzumab was labelled as Toclizumab and vice versa. This was due to a production error by the HSCIC. £ The National Institute for Health and Care Excellence (NICE) technology appraisal process assesses the clinical and cost effectiveness of new and existing medicines and treatments, and provides guidance on their use by the NHS. £ The Innovation Health and Wealth paper published by the Department of Health in December 2011, set out plans to support development and adoption of innovation in the NHS.£ One of the actions in this paper is to drive compliance with technology appraisals by the publication of information relating to levels of compliance and variation at a local level. The Heal

NICE Technology Appraisals in the NHS in England (Innovation Scorecard): to December 2016

Published: 12 July 2017 - The Innovation Scorecard reports on the use of medicines and medical technologies in the NHS in England, which have been positively appraised by the National Institute for Health and Care Excellence (NICE) since 2012.

Have a question? Call us on 0300 303 5678 or contact enquiries@nhsdigital.nhs.uk.

Tell us what you think of the new website beta.

We use cookies to provide you with a better service. Carry on browsing if you're happy with this, or find out how to manage cookies. Find out more